This report outlines KPMG viewpoints, as well as those of senior executives in China’s life sciences sector, on the prospects of the industry.
China’s life sciences industry has expanded at a faster rate than the economy as a whole. It remains one of the most buoyant sectors.
KPMG China interviewed a number of senior executives in producing Life Sciences: the CEO’s Perspective. This publication highlights key trends in the industry such as reforms to the drug tendering process and advances in data analytics and other technologies.